BMS-243117
BMS-243117 is a potent, and selective benzothiazole based p56Lck inhibitor with an IC50 of 4 nM. BMS-243117 inhibits anti-CD3/anti-CD28 induced PBL (human peripheral blood T-cells) proliferation with an IC50 of 1.1 μM. BMS-243117 binds in an extended conformation to the ATP-binding site of Lck.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 225521-80-2
- Fòrmula: C20H21ClN4O2S
- Peso molecular:416.92
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
Lck 4 nM (IC50) |
Fyn 32 nM (IC50) |
Blk 84 nM (IC50) |
Src 158 nM (IC50) |
Hck 960 nM (IC50) |
Lyn 330 nM (IC50) |
Fgr 60 nM (IC50) |
Chemical Information
-
No. CAS 225521-80-2
-
Peso molecular 416.92
-
Fòrmula C20H21ClN4O2S
-
SMILES
O=C(C1=CC=C2N=C(NC(NC(C)(C)C)=O)SC2=C1)NC3=C(C)C=CC=C3Cl
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BMS-243117 Related Classifications
HY-120622 Related Classifications
Powered by Bioz